REVIEW 1 cited by
False Discovery Rate Controlled Heterogeneous Treatment Effect Detection for Online Controlled Experiments
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
Signed reviews
read the original abstract
Online controlled experiments (a.k.a. A/B testing) have been used as the mantra for data-driven decision making on feature changing and product shipping in many Internet companies. However, it is still a great challenge to systematically measure how every code or feature change impacts millions of users with great heterogeneity (e.g. countries, ages, devices). The most commonly used A/B testing framework in many companies is based on Average Treatment Effect (ATE), which cannot detect the heterogeneity of treatment effect on users with different characteristics. In this paper, we propose statistical methods that can systematically and accurately identify Heterogeneous Treatment Effect (HTE) of any user cohort of interest (e.g. mobile device type, country), and determine which factors (e.g. age, gender) of users contribute to the heterogeneity of the treatment effect in an A/B test. By applying these methods on both simulation data and real-world experimentation data, we show how they work robustly with controlled low False Discover Rate (FDR), and at the same time, provides us with useful insights about the heterogeneity of identified user groups. We have deployed a toolkit based on these methods, and have used it to measure the Heterogeneous Treatment Effect of many A/B tests at Snap.
Forward citations
Cited by 1 Pith paper
-
Surv-IPTB: An Attention-Based Model for Estimating Individual Probability of Treatment Benefit with Survival Data
An attention model estimates individual treatment benefit probability in survival data by classifying pairwise treated-versus-control comparisons, with censored cases given soft interval-based labels.
Discussion (0). Continue with ORCID to comment.